94 related articles for article (PubMed ID: 1780765)
1. A safe approach to treatment of factor IX-deficient patients. Introduction and overview of treatment.
Aledort LM
Semin Hematol; 1991 Jul; 28(3 Suppl 6):1-2. PubMed ID: 1780765
[No Abstract] [Full Text] [Related]
2. Recombinant factor IX for the treatment of hemophilia B. Introduction.
Thompson A
Semin Hematol; 1998 Apr; 35(2 Suppl 2):1-3. PubMed ID: 9565159
[No Abstract] [Full Text] [Related]
3. Viral safety of recombinant factor IX.
Adamson S; Charlebois T; O'Connell B; Foster W
Semin Hematol; 1998 Apr; 35(2 Suppl 2):22-7. PubMed ID: 9565163
[TBL] [Abstract][Full Text] [Related]
4. Considerations governing factor IX product choice in hemophilia B.
Bray GL; Aledort LM
Transfusion; 1994 Jun; 34(6):554-5. PubMed ID: 8023402
[No Abstract] [Full Text] [Related]
5. Current management of hemophilia B.
Roberts HR; Eberst ME
Hematol Oncol Clin North Am; 1993 Dec; 7(6):1269-80. PubMed ID: 8294316
[TBL] [Abstract][Full Text] [Related]
6. [Current status of viral safety of virus inactivated factor VIII and IX concentrates in treatment of hemophilia].
Pollmann H
Infusionsther Transfusionsmed; 1994 Aug; 21 Suppl 1():80-3. PubMed ID: 8000261
[TBL] [Abstract][Full Text] [Related]
7. Thrombogenicity associated with factor IX complex concentrates.
Lusher JM
Semin Hematol; 1991 Jul; 28(3 Suppl 6):3-5. PubMed ID: 1780767
[No Abstract] [Full Text] [Related]
8. [Use of 2 preparations of factor IX concentrate in the treatment of a patient with hemophilia B].
den Ottolander GJ
Ned Tijdschr Geneeskd; 1972 Jul; 116(30):1278-82. PubMed ID: 5041298
[No Abstract] [Full Text] [Related]
9. Preclinical studies of recombinant factor IX.
Schaub R; Garzone P; Bouchard P; Rup B; Keith J; Brinkhous K; Larsen G
Semin Hematol; 1998 Apr; 35(2 Suppl 2):28-32. PubMed ID: 9565164
[TBL] [Abstract][Full Text] [Related]
10. Recombinant factor IX.
White GC; Beebe A; Nielsen B
Thromb Haemost; 1997 Jul; 78(1):261-5. PubMed ID: 9198163
[TBL] [Abstract][Full Text] [Related]
11. Preclinical studies of a monoclonal antibody-purified factor IX, Mononine.
Hrinda ME; Huang C; Tarr GC; Weeks R; Feldman F; Schreiber AB
Semin Hematol; 1991 Jul; 28(3 Suppl 6):6-14. PubMed ID: 1780768
[No Abstract] [Full Text] [Related]
12. Clinical evaluation of recombinant factor IX.
White G; Shapiro A; Ragni M; Garzone P; Goodfellow J; Tubridy K; Courter S
Semin Hematol; 1998 Apr; 35(2 Suppl 2):33-8. PubMed ID: 9565165
[TBL] [Abstract][Full Text] [Related]
13. Products for the treatment of hemophilia A and B prepared by ion exchange chromatography.
Sultan Y; Boyeldieu D; Stieltjes N
Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S59-60. PubMed ID: 8177717
[TBL] [Abstract][Full Text] [Related]
14. Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa.
Hedner U
Thromb Haemost; 1999 Aug; 82(2):531-9. PubMed ID: 10605747
[No Abstract] [Full Text] [Related]
15. Myocardial infarction during factor IX infusion in hemophilia B: case report and review of the literature.
Najaf SM; Malik A; Quraishi AU; Kazmi K; Kakepoto GN
Ann Hematol; 2004 Sep; 83(9):604-7. PubMed ID: 15205916
[TBL] [Abstract][Full Text] [Related]
16. [Prevention of severe haemophilia B with a factor IX concentrate (author's transl)].
Ludwig E; Lechner K
Dtsch Med Wochenschr; 1974 Jun; 99(25):1355-61. PubMed ID: 4836072
[No Abstract] [Full Text] [Related]
17. [A factor IX-concentrate for the treatment of haemophilia B].
Suomela H; Myllylä G
Duodecim; 1971; 87(1):31-8. PubMed ID: 5539580
[No Abstract] [Full Text] [Related]
18. [Non-activated and activated prothrombin complex concentrates, Proplex and Feiba, in the treatment of a hemophilia B patient with high titer inhibitor against factor IX].
Niiya K; Hirose S; Taguchi H; Miyoshi I
Rinsho Ketsueki; 1985 Jun; 26(6):980-4. PubMed ID: 3877825
[No Abstract] [Full Text] [Related]
19. [Clinical use of factor IX concentrates].
Nyman D
Schweiz Med Wochenschr; 1975 Sep; 105(37):1188-90. PubMed ID: 1215901
[TBL] [Abstract][Full Text] [Related]
20. [The treatment of inherited coagulation disorders].
Blombäck M; Nilsson IM
Lakartidningen; 1972 Dec; 69():Suppl 4:76-84. PubMed ID: 4540328
[No Abstract] [Full Text] [Related]
[Next] [New Search]
